ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma

Molecular Medicine

Volumn 16, Issue 9-10, 2010, Pages 400-408

  Chen, Pei Fen ^a,b   Luo, Ya Ling ^a   Wang, Wei ^a   Wang, Jiang Xin ^c   Lai, Wen Yan ^a   Hu, Si Ming ^a   Cheng, Kai Fan ^d   Al Abed, Yousef ^d  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

^c ARIZONA STATE UNIVERSITY   (United States)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 HYDROXYPHENYL) 4,5 DIHYDRO 5 ISOXAZOLE ACETIC ACID METHYL ESTER; ANTIINFLAMMATORY AGENT; DEXAMETHASONE; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; UPREGULATION;

AIRWAY REMODELING; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHRONIC DISEASE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; GOBLET CELLS; HUMANS; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; ISOXAZOLES; LUNG; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH; OVALBUMIN; PNEUMONIA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77956635478     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00128     Document Type: Article

References (42)

1. Roche WR, Beasley R, Williams JH, Holgate ST. (1989) Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1:520-4.
2. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. (1992) Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest. 101:916-21.
3. Wiggs BR, Bosken C, Paré PD, James A, Hogg JC. (1992) A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 145:1251-8.
4. Barnes PJ. (1998) Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. (Lond). 94:557-72.
5. Boulet LP, et al. (2000) Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 162:1308-13.
6. Irwin RS, Richardson ND. (2006) Side effects with inhaled corticosteroids: the physician′s perception. Chest. 130:41S-53S.
7. Leung DY, Bloom JW. (2003) Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 111:3-22.
8. Szefler SJ, et al. (2002) Significant variability in response to inhaled corticosteroids for persistent asthma. J. Allergy Clin. Immunol. 109:410-8.
9. Drazen JM, Silverman EK, Lee TH. (2000) Heterogeneity of therapeutic responses in asthma. Br. Med. Bull. 56:1054-70.
10. Chan MT, Leung DY, Szefler SJ, Spahn JD. (1998) Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J. Allergy Clin. Immunol. 101:594-601.
11. Calandra T, et al. (1995) MIF as a glucocorticoidinduced modulator of cytokine production. Nature. 377:68-71.
12. Magalhães ES, et al. (2007) Macrophage migration inhibitory factor is essential for allergic asthma but not for Th2 differentiation. Eur. J. Immunol. 37:1097-106.
13. Mizue Y, et al. (2005) Role of macrophage migration inhibitory factor in asthma. Proc. Natl. Acad. Sci. U. S. A. 102:14410-5.
14. Amano T, Nishihira J, Miki I. (2007) Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation. Inflamm. Res. 56:24-31.
15. Leung JC, et al. (2004) Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy. Nephrol. Dial. Transplant. 19:1976-85.
16. Chen G, Khalil N. (2006) TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir. Res. 7:2.
17. Holgate ST. (2000) Epithelial damage and response. Clin. Exp. Allergy 1:37-41.
18. Zhang S, Smartt H, Holgate ST, Roche WR. (1999) Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. Lab. Invest. 79:395-405.
19. Al-Abed Y, et al. (2005) ISO-1 binding to the tautomerase active site of MIF inhibits its proinflammatory activity and increases survival. J. Bio. Chem. 280:36541-4.
20. Jain VV, et al. (2002) CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J. Allergy. Clin. Immunol. 110:867-72.
21. Henderson WR Jr, et al. (2002) A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165:108-16.
22. Bai A, et al. (1994) Proposed nomenclature for quantifying subdivisions of the bronchial wall. J. Appl. Physiol. 77:1011-4.
23. Opazo Saez A, Du T, Wang NS, Martin JG. (1996) Methacholine-induced bronchoconstriction and airway smooth muscle in the guinea pig. J. Appl. Physiol. 80:437-44.
24. Vanacker NJ, Palmans E, Kips JC, Pauwels RA. (2001) Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am. J. Respir. Crit. Care Med. 163:674-9.
25. Kobayashi M, et al. (2006) Role of macrophage migration inhibitory factor in ovalbumininduced airway inflammation in rats. Eur. Respir. J. 27:726-34.
26. Alourfi Z, et al. (2005) Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner. J Mol. Endocrinol. 34:583-95.
27. Maxime V, Fitting C, Annane D, Cavaillon JM. (2005) Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock. J. Infect. Dis. 191:138-44.
28. Lan HY, et al. (1997) The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J. Exp. Med. 185:1455-65.
29. Huang XR, et al. (2001) Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology. 121:619-30.
30. Amin MA, et al. (2006) Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood. 107:2252-61.
31. Flood-Page P, et al. (2003) Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J. Clin. Invest. 112:1029-36.
32. Cho JY, et al. (2004) Inhibition of airway remodeling in IL-5-deficient mice. J. Clin. Invest. 113:551-60.
33. Humbles AA, et al. (2004) A critical role for eosinophils in allergic airways remodeling. Science. 305:1776-9.
34. Ohno I, et al. (1996) Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am. J. Respir. Cell Mol. Biol. 15:404-9.
35. Elias JA, Zhu Z, Chupp G, Homer RJ. (1999) Airway remodeling in asthma. J. Clin. Invest. 104:1001-6.
36. Boulet LP, et al. (1997) Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest. 112:45-52.
37. Busse W, Elias J, Sheppard D, Banks-Schlegel S. (1999) Airway remodeling and repair. Am. J. Respir. Crit. Care Med. 160:1035-42.
38. Wanner A. (1990) The role of mucus in chronic obstructive pulmonary disease. Chest. 97: 11S-5S.
39. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. (2003) Airway structural alterations selectively associated with severe asthma. Am. J. Respir. Crit. Care Med. 167: 1360-8.
40. Mitchell RA, Metz CN, Peng T, Bucala R. (1999) Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol. Chem. 274:18100-6.
41. Batra V, et al. (2004) Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin. Exp. Allergy. 34:437-44.
42. Minshall EM, et al. (1997) Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 17:326-33.